Cross Country Healthcare (CCRN) Competitors

$13.25 0.00 (0.00%)

As of 07/22/2026

CCRN vs. AGL, OMDA, INNV, PNTG, and AMN

Should you buy Cross Country Healthcare stock or one of its competitors? Cross Country Healthcare's main competitors and comparable companies include Agilon Health (AGL), Omada Health (OMDA), InnovAge (INNV), The Pennant Group (PNTG), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Cross Country Healthcare compare to Agilon Health?

Cross Country Healthcare (NASDAQ:CCRN) and Agilon Health (NYSE:AGL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Cross Country Healthcare presently has a consensus price target of $12.05, suggesting a potential downside of 9.06%. Agilon Health has a consensus price target of $91.30, suggesting a potential downside of 5.21%. Given Agilon Health's stronger consensus rating and higher possible upside, analysts clearly believe Agilon Health is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.21

96.0% of Cross Country Healthcare shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 2.5% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cross Country Healthcare has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Cross Country Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A
Agilon Health	$5.93B	0.27	-$391.35M	-$14.27	N/A

Agilon Health has a net margin of -3.92% compared to Cross Country Healthcare's net margin of -9.84%. Cross Country Healthcare's return on equity of -0.74% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
Agilon Health	-3.92%	-119.38%	-16.85%

In the previous week, Agilon Health had 4 more articles in the media than Cross Country Healthcare. MarketBeat recorded 4 mentions for Agilon Health and 0 mentions for Cross Country Healthcare. Agilon Health's average media sentiment score of 0.40 beat Cross Country Healthcare's score of 0.00 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Cross Country Healthcare	Neutral
Agilon Health	Neutral

Cross Country Healthcare has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, Agilon Health has a beta of 3.01, indicating that its share price is 201% more volatile than the broader market.

Summary

Cross Country Healthcare and Agilon Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to Omada Health?

Cross Country Healthcare (NASDAQ:CCRN) and Omada Health (NASDAQ:OMDA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Cross Country Healthcare currently has a consensus price target of $12.05, suggesting a potential downside of 9.06%. Omada Health has a consensus price target of $26.50, suggesting a potential upside of 10.93%. Given Omada Health's stronger consensus rating and higher possible upside, analysts plainly believe Omada Health is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
Omada Health	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.71

Omada Health has lower revenue, but higher earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Omada Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A
Omada Health	$260.21M	5.62	-$12.78M	$0.05	477.80

Cross Country Healthcare has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market. Comparatively, Omada Health has a beta of 1.73, meaning that its stock price is 73% more volatile than the broader market.

96.0% of Cross Country Healthcare shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 6.4% of Omada Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Omada Health had 6 more articles in the media than Cross Country Healthcare. MarketBeat recorded 6 mentions for Omada Health and 0 mentions for Cross Country Healthcare. Omada Health's average media sentiment score of 0.92 beat Cross Country Healthcare's score of 0.00 indicating that Omada Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Cross Country Healthcare	Neutral
Omada Health	Positive

Omada Health has a net margin of 1.39% compared to Cross Country Healthcare's net margin of -9.84%. Omada Health's return on equity of 2.60% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
Omada Health	1.39%	2.60%	1.98%

Summary

Omada Health beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to InnovAge?

InnovAge (NASDAQ:INNV) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 1.0% of InnovAge shares are owned by insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

InnovAge has higher earnings, but lower revenue than Cross Country Healthcare. InnovAge is trading at a lower price-to-earnings ratio than Cross Country Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$853.70M	1.74	-$30.31M	-$0.09	N/A
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A

InnovAge presently has a consensus price target of $10.00, suggesting a potential downside of 8.76%. Cross Country Healthcare has a consensus price target of $12.05, suggesting a potential downside of 9.06%. Given InnovAge's higher probable upside, equities analysts plainly believe InnovAge is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

In the previous week, InnovAge had 2 more articles in the media than Cross Country Healthcare. MarketBeat recorded 2 mentions for InnovAge and 0 mentions for Cross Country Healthcare. InnovAge's average media sentiment score of 1.67 beat Cross Country Healthcare's score of 0.00 indicating that InnovAge is being referred to more favorably in the media.

Company	Overall Sentiment
InnovAge	Very Positive
Cross Country Healthcare	Neutral

InnovAge has a beta of 0.39, suggesting that its share price is 61% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market.

InnovAge has a net margin of -1.22% compared to Cross Country Healthcare's net margin of -9.84%. Cross Country Healthcare's return on equity of -0.74% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

Summary

InnovAge and Cross Country Healthcare tied by winning 8 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to The Pennant Group?

Cross Country Healthcare (NASDAQ:CCRN) and The Pennant Group (NASDAQ:PNTG) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

The Pennant Group has a net margin of 2.93% compared to Cross Country Healthcare's net margin of -9.84%. The Pennant Group's return on equity of 10.33% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
The Pennant Group	2.93%	10.33%	4.20%

Cross Country Healthcare presently has a consensus target price of $12.05, suggesting a potential downside of 9.06%. The Pennant Group has a consensus target price of $41.60, suggesting a potential upside of 7.00%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts clearly believe The Pennant Group is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

The Pennant Group has lower revenue, but higher earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A
The Pennant Group	$947.71M	1.43	$29.58M	$0.90	43.20

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by insiders. Comparatively, 6.9% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cross Country Healthcare has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

In the previous week, The Pennant Group had 7 more articles in the media than Cross Country Healthcare. MarketBeat recorded 7 mentions for The Pennant Group and 0 mentions for Cross Country Healthcare. The Pennant Group's average media sentiment score of 1.00 beat Cross Country Healthcare's score of 0.00 indicating that The Pennant Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Cross Country Healthcare	Neutral
The Pennant Group	Positive

Summary

The Pennant Group beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Cross Country Healthcare has lower revenue, but higher earnings than AMN Healthcare Services. Cross Country Healthcare is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.49	-$95.70M	$2.68	12.87
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A

AMN Healthcare Services has a net margin of 3.06% compared to Cross Country Healthcare's net margin of -9.84%. AMN Healthcare Services' return on equity of 19.92% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

AMN Healthcare Services presently has a consensus price target of $31.43, suggesting a potential downside of 8.85%. Cross Country Healthcare has a consensus price target of $12.05, suggesting a potential downside of 9.06%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, research analysts clearly believe AMN Healthcare Services is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 6.3% of Cross Country Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

AMN Healthcare Services has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

In the previous week, AMN Healthcare Services had 8 more articles in the media than Cross Country Healthcare. MarketBeat recorded 8 mentions for AMN Healthcare Services and 0 mentions for Cross Country Healthcare. AMN Healthcare Services' average media sentiment score of 0.68 beat Cross Country Healthcare's score of 0.00 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company	Overall Sentiment
AMN Healthcare Services	Positive
Cross Country Healthcare	Neutral

Summary

AMN Healthcare Services beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks.

Get Cross Country Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCRN vs. The Competition

Export

Metric	Cross Country Healthcare	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$428.05M	$9.70B	$7.27B	$12.76B
Dividend Yield	N/A	2.55%	2.54%	11.09%
P/E Ratio	-4.34	29.55	210.91	21.07
Price / Sales	0.43	4.98	620.58	95.12
Price / Cash	25.11	124.12	76.89	53.23
Price / Book	1.35	4.05	13.43	6.37
Net Income	-$94.85M	$311.06M	$3.46B	$347.74M
7 Day Performance	N/A	0.83%	2.24%	0.08%
1 Month Performance	N/A	0.61%	5.14%	2.13%
1 Year Performance	-2.50%	17.52%	27.85%	20.64%

Cross Country Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCRN Cross Country Healthcare	1.8327 of 5 stars	$13.25 flat	$12.05 -9.1%	N/A	$428.05M	$1.00B	N/A	6,784
AGL Agilon Health	1.0607 of 5 stars	$96.32 -0.6%	$86.18 -10.5%	+209.6%	$1.63B	$5.93B	N/A	1,076
OMDA Omada Health	3.2042 of 5 stars	$23.75 -1.2%	$26.50 +11.6%	+10.1%	$1.47B	$260.21M	475.00	849
INNV InnovAge	2.0923 of 5 stars	$10.67 +0.6%	$7.00 -34.4%	+207.2%	$1.44B	$949.17M	N/A	2,440	News Coverage Positive News Analyst Upgrade Gap Up
PNTG The Pennant Group	4.0024 of 5 stars	$39.18 -0.4%	$41.20 +5.2%	+55.0%	$1.37B	$1.10B	43.53	9,700	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCRN) was last updated on 8/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cross Country Healthcare (CCRN) Competitors

CCRN vs. AGL, OMDA, INNV, PNTG, and AMN

How does Cross Country Healthcare compare to Agilon Health?

Summary

How does Cross Country Healthcare compare to Omada Health?

Summary

How does Cross Country Healthcare compare to InnovAge?

Summary

How does Cross Country Healthcare compare to The Pennant Group?

Summary

How does Cross Country Healthcare compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCRN vs. The Competition

Cross Country Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cross Country Healthcare (CCRN) Competitors

CCRN vs. AGL, OMDA, INNV, PNTG, and AMN

How does Cross Country Healthcare compare to Agilon Health?

Do analysts prefer CCRN or AGL?

Do institutionals & insiders hold more shares of CCRN or AGL?

Which has stronger valuation & earnings, CCRN or AGL?

Is CCRN or AGL more profitable?

Does the media refer more to CCRN or AGL?

Which has more volatility and risk, CCRN or AGL?

Summary

How does Cross Country Healthcare compare to Omada Health?

Do analysts recommend CCRN or OMDA?

Which has stronger valuation and earnings, CCRN or OMDA?

Which has more volatility and risk, CCRN or OMDA?

Do institutionals and insiders hold more shares of CCRN or OMDA?

Does the media refer more to CCRN or OMDA?

Is CCRN or OMDA more profitable?

Summary

How does Cross Country Healthcare compare to InnovAge?

Do insiders & institutionals hold more shares of INNV or CCRN?

Which has preferable earnings & valuation, INNV or CCRN?

Do analysts rate INNV or CCRN?

Does the media prefer INNV or CCRN?

Which has more volatility and risk, INNV or CCRN?

Is INNV or CCRN more profitable?

Summary

How does Cross Country Healthcare compare to The Pennant Group?

Is CCRN or PNTG more profitable?

Do analysts prefer CCRN or PNTG?

Which has preferable valuation & earnings, CCRN or PNTG?

Do institutionals and insiders believe in CCRN or PNTG?

Which has more volatility & risk, CCRN or PNTG?

Does the media refer more to CCRN or PNTG?

Summary

How does Cross Country Healthcare compare to AMN Healthcare Services?

Which has preferable earnings and valuation, AMN or CCRN?

Is AMN or CCRN more profitable?

Do analysts prefer AMN or CCRN?

Do institutionals & insiders hold more shares of AMN or CCRN?

Which has more volatility and risk, AMN or CCRN?

Does the media favor AMN or CCRN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCRN vs. The Competition

Cross Country Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools